# Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

> **NCT00767273** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **PROCEDURE:** PET Scan
- **DRUG:** FLT
- **DRUG:** FDG

## Key facts

- **NCT ID:** NCT00767273
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767273, "Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00767273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*